(Q36860273)

16 August 2017

1 reference

title

Varenicline: the newest agent for smoking cessation (English)

1 reference

16 August 2017

1 reference

Lisa A Potts

1

1 reference

PubMed ID

17592002

16 August 2017

Candice L Garwood

series ordinal

2

1 reference

16 August 2017

1 July 2007

1 reference

American Journal of Health-System Pharmacy

16 August 2017

1 reference

16 August 2017

64

1 reference

16 August 2017

13

1 reference

16 August 2017

1381-1384

1 reference

Cytisine for smoking cessation: a literature review and a meta-analysis

16 August 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Current pharmacological treatments for nicotine dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Expanding treatment of tobacco dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060428

31 March 2020

Identifiers

DOI

10.2146/AJHP060428

1 reference

16 August 2017

1 reference

PubMed ID

17592002